Abstract
Acne constitutes a multifactorial skin disorder which has a very adverse psychological impact in all individuals but more so in adolescents [1, 2]. From many natural paradigms and from systematic studies, the role of hormones in the appearance of acne has been substantiated [1–4]. Specifically, androgens affect the pilosebaseous unit by inducing sebum production [5].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ballanger F, Baudry P, N’Guy JM, et al. Heredity: a prognostic factor for acne. Dermatology. 2006;212:145–9.
Cunliffe WJ, Baron SE, Coulson IH. A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol. 2001;145:463–6.
Cordera F, Grant C, van Heerden J, et al. Androgen – secreting adrenal tumours. Surgery. 2003;134:874–80.
Dreno B, Poli F. Epidemiology of acne. Dermatology. 2003;206:7–10.
Jansen T, Burgdorf WHC, Plewing G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol. 1997;14:14–274.
De Raeve L, De Schepper J, Smitz J. Prepubertal acne: a cutaneous marker of androgen excess? J Am Acad Dermatol. 1995;32:181–4.
New MI. An repdate of congenital adrenal hyperplasia. Ann N Y Acad Sci. 2004;1038:14–43.
Dacou-Voutetakis C, Dracopoulou M. High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche. J Clin Endocrinol Metab. 1999;84:1570–4.
Dacou-Voutetakis C, Dracopoulou M. Non-classical congenital adrenal hyperplasia. Pediatr Endocrinol Rev. 2006;3:195–7.
Dracopoulou-Vabouli M, Maniati-Christidi M, Dacou-Voutetakis C. The spectrum of Molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperpasia. J Clin Endocrinol Metab. 2001;86:2845–8.
Harde V, Műller M, Sippel WG, et al. Acne infantum as presenting symptom of congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. JDDG. 2006;4:654–7.
Dacou-Voutetakis C, Livadas S, Voutetakis A, et al. Adrenarche, premature. Encyclopedia of endocrine diseases. Elsevier Inc.; 2004. Pp 99–105.
Ibanez I, Bonnin MR, Zampoli M, et al. Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche. Horm Res. 1995;44:51–6.
Witchel SF, Lee PA. Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests. Am J Med Genet. 1998;76:337–42.
Ostleve LS, Rumsby G, Holownia P, et al. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol (Oxf). 1998;48:209–15.
Ibanez L, Dimartino-Nardi J, Potau N, et al. Premature adrenarche – normal variant or fore runner of adult disease? Endocr Rev. 2000;6:671–96.
Thalmann S, Meier CA. Acne and “mild” adrenal hyperplasia. Dermatology. 2006;213:277–8.
Degitz K, Placzek M, Arnold B, et al. Congenital adrenal hyperplasia and acne in male patients. Br J Dermatol. 2003;148:1263–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dacou-Voutetakis, C. (2014). Acne and Congenital Adrenal Hyperplasia. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_46
Download citation
DOI: https://doi.org/10.1007/978-3-540-69375-8_46
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69374-1
Online ISBN: 978-3-540-69375-8
eBook Packages: MedicineMedicine (R0)